Darwin Bioprospecting Excellence Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 23

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 14

Darwin Bioprospecting Excellence General Information

Description

Developer of a bioprospecting platform designed to provide microbial research for the medical field. The company's platform deals with microbiome sequencing, food starters, probiotics, energy and environment research in carotenoid-producing microorganisms, adaptation, and optimization of bioinformatics pipelines for the MinION technology, enabling medical research institutes to do personalized sampling, culturing, sequencing, and production strategies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Calle Catedrático Agustín
  • Escardino, 9
  • 46980 Paterna
  • Spain
+34 962
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Calle Catedrático Agustín
  • Escardino, 9
  • 46980 Paterna
  • Spain
+34 962

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Darwin Bioprospecting Excellence Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Accelerator/Incubator Completed Generating Revenue
10. Later Stage VC 06-Feb-2025 Completed Generating Revenue
9. Accelerator/Incubator 01-Mar-2023 Completed Generating Revenue
8. Accelerator/Incubator Completed Generating Revenue
7. Grant 06-Oct-2021 Completed Generating Revenue
6. Grant 12-Mar-2021 Completed Generating Revenue
5. Accelerator/Incubator 30-Jul-2020 Completed Generating Revenue
4. Early Stage VC 01-Jan-2019 Completed Startup
3. Grant Completed Startup
2. Accelerator/Incubator Completed Startup
To view Darwin Bioprospecting Excellence’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Darwin Bioprospecting Excellence Patents

Darwin Bioprospecting Excellence Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-3010324-A1 Fermented dairy product Pending 28-Jun-2024
WO-2026003402-A1 Fermented dairy product Pending 28-Jun-2024
ES-2973007-A1 Oral probiotic Active 11-Jan-2024
ES-2973007-A8 Oral probiotic Active 11-Jan-2024
ES-2973007-B2 Oral probiotic Active 11-Jan-2024 A61K35/744
To view Darwin Bioprospecting Excellence’s complete patent history, request access »

Darwin Bioprospecting Excellence Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Darwin Bioprospecting Excellence Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biozell Ventures Corporate Venture Capital Minority
Repsol Corporate Venturing Corporate Venture Capital Minority
Scale the Impact Accelerator/Incubator
CEEI Accelerator/Incubator
L'Institut Valencià de Competitivitat Empresarial Government
You’re viewing 5 of 14 investors. Get the full list »

Darwin Bioprospecting Excellence FAQs

  • When was Darwin Bioprospecting Excellence founded?

    Darwin Bioprospecting Excellence was founded in 2016.

  • Where is Darwin Bioprospecting Excellence headquartered?

    Darwin Bioprospecting Excellence is headquartered in Paterna, Spain.

  • What is the size of Darwin Bioprospecting Excellence?

    Darwin Bioprospecting Excellence has 23 total employees.

  • What industry is Darwin Bioprospecting Excellence in?

    Darwin Bioprospecting Excellence’s primary industry is Drug Discovery.

  • Is Darwin Bioprospecting Excellence a private or public company?

    Darwin Bioprospecting Excellence is a Private company.

  • What is Darwin Bioprospecting Excellence’s current revenue?

    The current revenue for Darwin Bioprospecting Excellence is .

  • Who are Darwin Bioprospecting Excellence’s investors?

    Biozell Ventures, Repsol Corporate Venturing, Scale the Impact, CEEI, and L'Institut Valencià de Competitivitat Empresarial are 5 of 14 investors who have invested in Darwin Bioprospecting Excellence.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process